These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30378564)

  • 1. [Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].
    Boyko SS; Zherdev VP; Shevchenko RV
    Biomed Khim; 2018 Sep; 64(5):455-458. PubMed ID: 30378564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain].
    Molodavkin GM; Borlikova GG; Voronina TA; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(2):3-5. PubMed ID: 12109288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The original novel nootropic and neuroprotective agent noopept].
    Ostrovskaia RU; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(5):66-72. PubMed ID: 12596521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
    J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Design of the novel dipeptide neuropsychotropic drug preparations].
    Gudasheva TA; Skoldinov AP
    Eksp Klin Farmakol; 2003; 66(2):15-9. PubMed ID: 12962042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopropyl glycine and proline-containing preparation noopept evoke two types of membrane potential responses in synaptoneurosomes.
    Lutsenko VK; Vukolova MN; Gudasheva TA
    Bull Exp Biol Med; 2003 Jun; 135(6):559-62. PubMed ID: 12937673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interspecies differences of noopept pharmacokinetics].
    Boĭko SS; Korotkov SA; Zherdev VP; Gudasheva TA; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):40-3. PubMed ID: 15079908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of noopept in streptozotocin-induced diabetes in rats.
    Ostrovskaya RU; Ozerova IV; Gudascheva TA; Kapitsa IG; Ivanova EA; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2013 Jan; 154(3):334-8. PubMed ID: 23484194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of the neuroprotection concept].
    Ostrovskaia RU
    Eksp Klin Farmakol; 2003; 66(2):32-7. PubMed ID: 12962045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of noopept on cognitive functions and pubertal process in rats with diabetes.
    Gürbüz P; Düzova H; Yildiz A; Çakan P; Kaya GB; Bağ HGG; Durhan M; Gül CC; Taşlidere AÇ
    Life Sci; 2019 Sep; 233():116698. PubMed ID: 31356906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Noopept improves the spatial memory and stimulates prefibrillar beta-amyloid(25-35) antibody production in mice].
    Bobkova NV; Gruden' MA; Samokhin AN; Medvinskaia NI; Morozova-Roch L; Uudasheva TA; Ostrovskaia RU; Seredinin SB
    Eksp Klin Farmakol; 2005; 68(5):11-5. PubMed ID: 16277202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noopept normalizes parameters of the incretin system in rats with experimental diabetes.
    Ostrovskaya RU; Zolotov NN; Ozerova IV; Ivanova EA; Kapitsa IG; Taraban KV; Michunskaya AM; Voronina TA; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2014 Jul; 157(3):344-9. PubMed ID: 25065315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration.
    Ostrovskaya RU; Mirsoev TK; Romanova GA; Gudasheva TA; Kravchenko EV; Trofimov CC; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2001 Oct; 132(4):959-62. PubMed ID: 11782792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the mechanism of noopept action: decrease in activity of stress-induced kinases and increase in expression of neutrophines].
    Ostrovskaia RU; Vakhitova IuV; Salimgareeva MKh; Iamidanov RS; Sadovnikov SV; Kapitsa IG; Seredenin SB
    Eksp Klin Farmakol; 2010 Dec; 73(12):2-5. PubMed ID: 21395007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats).
    Ostrovskaya RU; Belnik AP; Storozheva ZI
    Bull Exp Biol Med; 2008 Jul; 146(1):77-80. PubMed ID: 19145356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB
    Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect].
    Gudasheva TA; Ostrovskaia RU; Trofimov SS; Voronina TA; Skoldinov AP; Seredenin SB
    Biull Eksp Biol Med; 1999 Oct; 128(10):411-3. PubMed ID: 10599497
    [No Abstract]   [Full Text] [Related]  

  • 18. [The original nootropic and neuroprotective drug noopept potentiates the anticonvulsant activity of valproate in mice].
    Kravchenko EV; Ponteleeva IV; Trofimov SS; Lapa VI; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2009; 72(6):15-7. PubMed ID: 20095393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of learning and memory after photothrombosis of the prefrontal cortex in rat brain: effects of Noopept.
    Romanova GA; Shakova FM; Gudasheva TA; Ostrovskaya RU
    Bull Exp Biol Med; 2002 Dec; 134(6):528-30. PubMed ID: 12660828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of synaptic transmission in memory and neurodegeneration processes and effects of neurotropic preparations].
    Voronina TA
    Eksp Klin Farmakol; 2003; 66(2):10-4. PubMed ID: 12962041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.